TrialDiabetes care2011

Chronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetes.

Christian Pennartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.